Mostrando 3 resultados de: 3
Publisher
Current Pharmaceutical Design(1)
Frontiers in Bioscience - Landmark(1)
Journal of Biomedical Science(1)
Área temáticas
Enfermedades(2)
Farmacología y terapéutica(2)
Bioquímica(1)
Fisiología humana(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Área de conocimiento
Neurología(2)
Biología molecular(1)
Farmacología(1)
Medicamento(1)
Medicina interna(1)
Origen
scopus(3)
Impact of New Drugs for Therapeutic Intervention in Alzheimer’s Disease
ReviewAbstract: The increases in population ageing and growth are leading to a boosting in the number of people liviPalabras claves:clinical studies, dementia, neuroinflammation, novel therapies, synapsesAutores:Antoni Camins, Auladell C., Cano A., Carrasco M., Espinosa T., Ettcheto M., Folch J., Gudiño-Cabrera G., Olloquequi J., Sanchez-Lopez E., Ureña-Guerrero M.E., Verdaguer E., Zárate C.B.Fuentes:scopusKB-R7943 reduces 4-aminopyridine-induced epileptiform activity in adult rats after neuronal damage induced by neonatal monosodium glutamate treatment
ArticleAbstract: Background: Neonatal monosodium glutamate (MSG) treatment triggers excitotoxicity and induces a degePalabras claves:Entorhinal cortex, hippocampus, KB-R7943, Monosodium glutamate, NCX1-3, seizuresAutores:Antoni Camins, Cardenas-Castillo J.A., Gutierrez-Barajas P.E., Hernandez-Ojeda M., Ureña-Guerrero M.E., Zárate C.B.Fuentes:scopusReceptor to glutamate NMDA-type: The functional diversity of the NR1 isoforms and pharmacological properties
ArticleAbstract: Glutamic acid (Glu) is the major excitatory neurotransmitter in the central nervous system, and intePalabras claves:Excitotoxicity, Isoform, NMDA receptor, NR1 Subunit, NR2 SubunitAutores:Antoni Camins, Chaparro-Huerta V., Escoto-Delgadillo M., Flores-Soto M.E., Ureña-Guerrero M.E., Zárate C.B.Fuentes:scopus